PetIQ (PETQ) Stock Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free PETQ Stock Alerts $16.53 +0.21 (+1.29%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media PetIQ Stock Price Performance5 Day Performance+1.54%1 Month Performance-7.08%3 Month Performance-9.52%6 Month Performance-11.18%Year-To-Date Performance-16.30%1 Year Performance+43.49% Receive PETQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> PETQ Stock Chart for Friday, April, 26, 2024 PETQ Chart by TradingView PetIQ Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$16.53$16.32-1.27%$16.37$16.09146,894 shs$480.31 million04/24/2024$16.60$16.53-0.42%$16.67$16.45167,651 shs$486.48 million04/23/2024$16.51$16.60+0.55%$16.79$16.41207,168 shs$488.54 million04/22/2024$16.28$16.51+1.41%$16.58$16.27181,499 shs$485.89 million04/19/2024$16.03$16.28+1.56%$16.43$15.95162,976 shs$479.12 million04/18/2024$15.93$16.03+0.63%$16.34$15.88219,622 shs$471.76 million Get the Latest News and Ratings for PETQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$16.20$15.93-1.67%$16.52$15.78222,152 shs$468.82 million04/16/2024$16.18$16.20+0.12%$16.33$15.75282,930 shs$476.77 million04/15/2024$16.46$16.18-1.70%$16.73$16.15227,926 shs$476.18 million04/12/2024$17.31$16.46-4.91%$17.45$16.40261,968 shs$484.42 million04/11/2024$17.75$17.31-2.48%$17.87$17.31226,363 shs$509.45 million04/10/2024$18.16$17.75-2.26%$17.87$17.51214,467 shs$522.38 million04/09/2024$18.23$18.16-0.38%$18.37$17.89132,666 shs$534.45 million04/08/2024$18.39$18.23-0.87%$18.55$18.11153,030 shs$536.51 million04/05/2024$18.56$18.39-0.92%$18.75$18.08136,970 shs$541.22 million04/04/2024$18.71$18.56-0.80%$19.16$18.49364,255 shs$546.22 million04/03/2024$18.24$18.71+2.58%$18.73$18.09182,104 shs$550.64 million04/02/2024$18.49$18.24-1.35%$18.61$17.97214,407 shs$536.80 million04/01/2024$18.28$18.49+1.15%$18.68$17.92630,555 shs$544.18 million03/29/2024$18.28$18.28$18.39$17.49350,928 shs$537.98 million03/28/2024$17.44$18.28+4.82%$18.39$17.51350,928 shs$537.98 million03/27/2024$17.79$17.44-1.97%$18.19$17.38296,013 shs$513.26 million03/26/2024$17.39$17.79+2.30%$17.81$17.32266,507 shs$523.58 million03/25/2024$17.48$17.39-0.51%$17.79$17.32203,039 shs$511.79 million03/22/2024$17.60$17.48-0.68%$17.90$17.29680,476 shs$514.44 million03/21/2024$17.15$17.60+2.62%$17.72$16.99376,670 shs$517.97 million03/20/2024$17.21$17.15-0.35%$17.26$16.65222,982 shs$504.72 million03/19/2024$15.56$17.21+10.60%$17.23$15.87440,597 shs$506.49 million03/18/2024$15.78$15.56-1.39%$15.94$15.54215,197 shs$457.93 million03/15/2024$15.55$15.78+1.48%$15.82$15.09656,915 shs$464.41 million03/14/2024$16.57$15.55-6.16%$16.40$15.50410,040 shs$457.64 million03/13/2024$16.57$16.57$16.65$16.40164,853 shs$487.66 million03/12/2024$16.43$16.57+0.85%$16.71$16.35256,725 shs$487.67 million03/11/2024$16.32$16.43+0.67%$16.70$16.02492,883 shs$483.54 million03/08/2024$16.10$16.32+1.37%$16.69$16.27459,813 shs$480.30 million03/07/2024$16.18$16.10-0.49%$16.42$16.07312,885 shs$476.13 million03/06/2024$16.57$16.18-2.35%$16.75$16.01316,179 shs$476.18 million03/05/2024$16.78$16.57-1.25%$16.75$16.36515,382 shs$487.66 million03/04/2024$17.37$16.78-3.40%$17.36$16.74415,011 shs$493.84 million03/01/2024$18.21$17.37-4.61%$18.29$17.17469,036 shs$511.20 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>02/29/2024$18.32$18.21-0.60%$19.69$17.81808,373 shs$535.92 million02/28/2024$18.67$18.32-1.87%$18.81$18.28270,263 shs$539.16 million02/27/2024$18.33$18.67+1.85%$18.81$18.39227,915 shs$549.40 million02/26/2024$18.28$18.33+0.27%$18.68$18.18275,613 shs$539.45 million02/23/2024$17.68$18.28+3.39%$18.36$17.61244,263 shs$537.98 million02/22/2024$17.87$17.68-1.06%$17.98$17.61229,234 shs$520.27 million02/21/2024$18.63$17.87-4.08%$18.78$17.83195,280 shs$525.91 million02/20/2024$18.84$18.63-1.11%$18.80$18.45164,687 shs$548.28 million02/19/2024$18.84$18.84$19.18$18.71263,400 shs$554.46 million02/16/2024$19.04$18.84-1.05%$19.18$18.71263,477 shs$554.46 million02/15/2024$18.28$19.04+4.16%$19.06$18.42349,288 shs$560.35 million02/14/2024$17.86$18.28+2.35%$18.38$17.88219,092 shs$537.98 million02/13/2024$18.53$17.86-3.62%$18.07$17.61233,459 shs$525.62 million02/12/2024$17.85$18.53+3.81%$18.71$17.85438,426 shs$545.28 million02/09/2024$17.68$17.85+0.96%$18.15$17.64272,388 shs$525.33 million02/08/2024$17.31$17.68+2.14%$17.72$17.07505,525 shs$520.32 million02/07/2024$17.85$17.31-3.03%$17.81$17.27478,826 shs$509.43 million02/06/2024$17.84$17.85+0.06%$18.12$17.76242,853 shs$525.33 million02/05/2024$18.16$17.84-1.76%$18.17$17.76160,021 shs$525.03 million02/02/2024$18.29$18.16-0.71%$18.33$17.94176,419 shs$534.45 million02/01/2024$17.97$18.29+1.78%$18.38$17.99245,622 shs$538.28 million01/31/2024$17.59$17.97+2.16%$18.53$17.66401,576 shs$528.86 million01/30/2024$18.12$17.59-2.92%$18.04$17.48368,319 shs$517.67 million01/29/2024$18.27$18.12-0.82%$18.38$18.04234,212 shs$533.22 million01/26/2024$18.13$18.27+0.77%$18.40$18.03176,150 shs$537.69 million01/25/2024$18.24$18.13-0.60%$18.44$18.08110,181 shs$533.57 million Related Companies: Editas Medicine Stock Chart Taysha Gene Therapies Stock Chart Theravance Biopharma Stock Chart MultiPlan Stock Chart C4 Therapeutics Stock Chart Travere Therapeutics Stock Chart Oculis Stock Chart Nevro Stock Chart Larimar Therapeutics Stock Chart Annexon Stock Chart Receive PETQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PETQ) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PetIQ, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.